Skip to main content

Roche Licenses Melting Curve, SYBR Green Tech to Takara Bio for Use in Real-Time PCR Instruments and Kits

Premium

Roche Diagnostics said today that it has signed a license agreement with Takara Bio of Shiga, Japan, that gives Takara the right to use melting curve analysis technology and SYBR Green techniques in kits and instruments for real-time PCR.

Specifically, the agreement gives Takara a non-exclusive license for the use of the technology with instruments in Japan, and for worldwide use in kits, in the field of research applications.

Financial terms of the agreement were not disclosed.

The agreement covers reagents and/or methods using SYBR Green I technology and melting curve analysis for real-time PCR. The technologies are part of an intellectual property portfolio maintained by Roche in cooperation with Idaho Technology.

The agreement follows a licensing agreement for the SYBR Green and melting curve analysis technology that Idaho Technologies announced earlier this week with Kapa Biosystems.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.